Amrutanjan Buyback 2023 Record Date, Buyback Price, Entitlement Ratio
Amrutanjan Health Care, founded in 1936 and headquartered in Chennai, Tamil Nadu, is a prominent Indian OTC (over-the-counter) company. It is renowned for its unique blend of Ayurveda and modern science, offering products that facilitate quick and natural healing. With its flagship yellow-colored balm introduced in 1893, Amrutanjan became synonymous with pain relief and a trusted solution for headaches and body aches.
Introduction
In this article, we will delve into the details of the Amrutanjan Health Care buyback for the year 2023. We will explore the key aspects such as the record date, buyback price, entitlement ratio, and other pertinent information related to the buyback.
Amrutanjan Health Care Products
Amrutanjan Health Care offers a diverse range of products, which can be broadly classified into the following segments:
- Pain Management
- Congestion Management
- Women’s Hygiene
- Beverages
- Other Products
Some of the notable products in Amrutanjan’s portfolio include the New Maha Strong Pain Balm, Roll-on, Stick-on Patch, Relief Cough Syrup, Relief Swas Mint, Comfy Snug Fit, Amrutanjan Stop Pain Dental Gel, Decorn Corn Caps, Fruitnik, and Fruitnik Electro+.
Amrutanjan Share Buyback 2023 Details
The buyback details for Amrutanjan Health Care in 2023 are as follows:
- Amrutanjan Buyback Dates: Coming soon
- Amrutanjan Buyback Price: INR 900 per share
- Market Price on Buyback Approval: INR 736 per share
- Buyback Premium on Market Price: 22.28%
- Buyback Offer Size (Shares): 3,20,000 shares
- Buyback Offer Size (Amount): INR 28.80 crore
- Offer Type: Tender
- Promoter Participation: Yes
- Face Value: INR 1 per share
- Listing At: BSE, NSE
Amrutanjan Buyback Dates (Timeline)
To provide you with a clear timeline of the Amrutanjan buyback, here are the important dates:
- Board Meeting Intimation for Buyback Proposal: 26 June 2023
- Buyback Approval Date: 30 June 2023
- Public Announcement of Buyback: 3 July 2023
- Amrutanjan Buyback Record Date: 13 July 2023
- Buyback Opening Date: Coming soon
- Buyback Closing Date: Coming soon
- Cut-off Date to receive completed tender forms by Registrar: Coming soon
- Verification Date by the Registrar: Coming soon
- Return of unaccepted shares by Registrar: Coming soon
- Extinguishment of accepted shares: Coming soon
Amrutanjan Health Care Buyback Entitlement Ratio
The entitlement ratio for the Amrutanjan Health Care buyback is as follows:
- Small Shareholders (less than INR 2 Lakh on record date): 4.50%
A small shareholder is defined as an individual holding shares worth less than INR 2,00,000 as of the record date.
Amrutanjan Health Care Financial Performance
Let’s take a look at the financial performance of Amrutanjan Health Care over the past three fiscal years:
| FY 2021 | FY 2022 | FY 2023 |
|---|---|---|
| Revenue | 332.84 | 405.84 |
| Total Expenses | 258.59 | 326.85 |
| Net Income | 61.19 | 67.19 |
Figures are in INR crores unless specified otherwise.
Calculation of Investment in Buyback
To calculate the investment in the Amrutanjan buyback, we consider the following assumptions:
- Maximum market value of a shareholder as of the record date: INR 2,00,000
- Buyback price per share: INR 900
- Closing price of the stock as of 30 June 2023: INR 736
Based on these assumptions, the maximum shares a small shareholder can invest in the buyback is determined as follows:
INR 2,00,000 / INR 900 = 223 shares*
*The number of shares may vary based on the closing price on the record date.
To calculate the maximum amount invested in the buyback, we multiply the closing price on the buyback approval date (INR 736) by the number of shares (223):
INR 736 x 223 shares = INR 1,64,128
Amrutanjan Health Care Buyback Acceptance Ratio
The acceptance ratio for the Amrutanjan Health Care buyback depends on the number of shares tendered and the entitlement ratio. Here are a few scenarios:
- Shares Tendered: 223
- Buyback Entitlement: 11
- Acceptance Ratio: 11 (100%)
- Buyback Profit: INR 1,804
- Profit in %: 1.10%
- Shares Tendered: 223
- Buyback Entitlement: 11
- Acceptance Ratio: 22 (200%)
- Buyback Profit: INR 3,608
- Profit in %: 2.20%
- Shares Tendered: 223
- Buyback Entitlement: 11
- Acceptance Ratio: 33 (300%)
- Buyback Profit: INR 5,412
- Profit in %: 3.30%
Conclusion
In conclusion, the Amrutanjan Health Care buyback in 2023 presents an opportunity for shareholders to participate in the company’s buyback offer. With an attractive buyback price and a favorable acceptance ratio, shareholders can potentially profit from their investment in the buyback. It is essential to stay updated with the buyback timeline and fulfill the necessary requirements to participate successfully.
FAQs
How does the record date affect eligibility for the buyback?
The record date is the date set by the company to determine the eligibility of shareholders for participating in the buyback. Shareholders who own shares on or before the record date are eligible to participate.
What is the buyback price?
The buyback price is the price at which the company is willing to repurchase its shares from shareholders during the buyback program.
How does the buyback size affect shareholders?
The buyback size indicates the amount of capital allocated for repurchasing shares. A larger buyback size often suggests a stronger commitment from the company to return value to its shareholders.
Why is retail reservation important in a buyback?
Retail reservation ensures that small retail shareholders have a fair chance to participate in the buyback, even if they hold a relatively small number of shares. It allows retail investors to benefit from the buyback program alongside larger institutional investors
